KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Shares Repurchased (2022 - 2025)

GoodRx Holdings (GDRX) has disclosed Shares Repurchased for 4 consecutive years, with $9.4 million as the latest value for Q4 2025.

  • Quarterly Shares Repurchased rose 4915.96% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $216.4 million through Dec 2025, up 36.22% year-over-year, with the annual reading at $216.4 million for FY2025, 36.22% up from the prior year.
  • Shares Repurchased hit $9.4 million in Q4 2025 for GoodRx Holdings, down from $61.1 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $153.2 million in Q1 2024 to a low of $188000.0 in Q4 2024.
  • Historically, Shares Repurchased has averaged $44.7 million across 4 years, with a median of $18.0 million in 2022.
  • Biggest five-year swings in Shares Repurchased: tumbled 99.76% in 2024 and later surged 4915.96% in 2025.
  • Year by year, Shares Repurchased stood at $18.0 million in 2022, then soared by 333.42% to $77.8 million in 2023, then crashed by 99.76% to $188000.0 in 2024, then soared by 4915.96% to $9.4 million in 2025.
  • Business Quant data shows Shares Repurchased for GDRX at $9.4 million in Q4 2025, $61.1 million in Q3 2025, and $61.0 million in Q2 2025.